The U.S. Military banned Moderna’s mRNA flu shot after receiving letter from the McCullough Foundation
X Post
Nicolas Hulscher, MPH
The U.S. Military BANNED Moderna’s mRNA flu shot just one week after we sent our study to RFK Jr. and top public health leadership.
We found mFLUSIVA is one of the most DANGEROUS and INEFFECTIVE products ever approved.
The FDA staffers involved in its approval exhibited DERELICTION OF DUTY and should be fired immediately.
They should NEVER have approved a gene therapy that requires 3,798 ADVERSE EVENTS, 278 DISABLING REACTIONS, and 2 DEATHS to theoretically “prevent” 1 flu hospitalization.
Letter Sent to Secretary Kennedy and Federal Health Officials
The findings are deeply concerning. In the pivotal efficacy trial, approximately 5,017 adults had to receive mFLUSIVA instead of a standard-dose influenza vaccine to avert a single hospitalization. On that same scale, the switch was associated with approximately 1,454 additional solicited adverse reactions, 233 additional Grade 3 systemic reactions severe enough to prevent normal daily activity, and approximately 2 excess unexplained deaths.
Expressed another way, among 5,017 mFLUSIVA recipients, approximately 3,798 would experience a solicited adverse reaction and approximately 278 would experience a Grade 3 systemic reaction, while the demonstrated clinical benefit is one hospitalization averted.
The mortality findings are especially difficult to dismiss. Unexplained deaths were 2.55-fold more frequent among mFLUSIVA recipients, and related pooled fatal-event terms were also significantly elevated. Yet no properly adjudicated influenza-mortality endpoint was ever specified, collected, or reported anywhere in the development program, and no autopsy was performed on any mFLUSIVA recipient whose death remained unexplained.